Gastrointestinal involvement in children with SARS-COV-2 infection: An overview for the pediatrician.


Journal

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
ISSN: 1399-3038
Titre abrégé: Pediatr Allergy Immunol
Pays: England
ID NLM: 9106718

Informations de publication

Date de publication:
11 2020
Historique:
received: 24 08 2020
revised: 06 09 2020
accepted: 07 09 2020
entrez: 25 11 2020
pubmed: 26 11 2020
medline: 15 12 2020
Statut: ppublish

Résumé

Gastrointestinal symptoms are common findings in children with SARS-CoV-2 infection. Diarrhea and vomiting have been reported in about 8%-9% of cases, reaching more than 20% in some studies. Children with gastrointestinal involvement appear to be younger than those without, but the severity of the disease seems to be similar between the two groups of subjects. Fecal shedding in children has been reported in 20%-30% of children and has been observed in both those with and those without overt gastrointestinal involvement. Moreover, prolonged fecal elimination, lasting several days after negativization of real-time polymerase chain reaction assay on respiratory swabs, has been reported with variable frequency in children with SARS-CoV-2 infection. These observations raise the question regarding the possibility of oral-fecal transmission and the possible role of children in spreading the infection, particularly when they appear asymptomatic or with gastrointestinal symptoms but with no respiratory involvement, as well as during their convalescent phase.

Identifiants

pubmed: 33236437
doi: 10.1111/pai.13373
pmc: PMC7753808
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-95

Informations de copyright

© 2020 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

Références

Eur J Pediatr. 2020 Jul;179(7):1029-1046
pubmed: 32424745
Pediatr Infect Dis J. 2020 Jul;39(7):e133-e134
pubmed: 32304466
Indian Pediatr. 2020 Jun 15;57(6):533-535
pubmed: 32562397
JAMA Pediatr. 2020 Sep 1;174(9):882-889
pubmed: 32320004
N Engl J Med. 2020 Jul 9;383(2):187-190
pubmed: 32356945
J Gastroenterol Hepatol. 2020 May;35(5):744-748
pubmed: 32215956
Gut. 2020 May 19;:
pubmed: 32430348
J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):366-369
pubmed: 32444874
Nat Med. 2020 Apr;26(4):502-505
pubmed: 32284613
Pediatr Allergy Immunol. 2020 Nov;31 Suppl 26:92-95
pubmed: 33236437
Gut. 2020 Jun;69(6):1143-1144
pubmed: 32139552

Auteurs

Elena Chiappini (E)

Infectious Disease Unit, Department of Science Health, Meyer Children's Hospital, University of Florence, Florence, Italy.

Amelia Licari (A)

Pediatric Clinic, Fondazione IRCCS, Policlinico San Matteo, University of Pavia, Pavia, Italy.

Marco Antonio Motisi (MA)

Infectious Disease Unit, Department of Science Health, Meyer Children's Hospital, University of Florence, Florence, Italy.

Sara Manti (S)

Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.

Gian Luigi Marseglia (GL)

Pediatric Clinic, Fondazione IRCCS, Policlinico San Matteo, University of Pavia, Pavia, Italy.

Luisa Galli (L)

Infectious Disease Unit, Department of Science Health, Meyer Children's Hospital, University of Florence, Florence, Italy.

Paolo Lionetti (P)

Gastroenterology and Nutrition Unit, Meyer Children's Hospital, Department of Neurology, Pharmacology, Psychology and Child Health (NEUROFARBA), University of Florence, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH